Position in ANTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,377,381
+$2,397,391 QoQ
Shares Held
697,806
+143.5% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 66 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ANTX ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ANTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,377,381 | 697,806 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $979,990 | 286,547 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $287,137 | 251,875 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $316,675 | 249,351 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $264,311 | 249,351 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $345,334 | 253,923 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $314,357 | 227,796 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $235,572 | 220,162 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $388,983 | 180,923 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $582,952 | 179,370 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,659,985 | 178,623 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,442,231 | 89,691 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $450,177 | 52,962 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,430,626 | 144,947 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,173,000 | 123,085 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,447,597 | 83,291 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $592,619 | 76,467 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||